| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |